Maria Caino
Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 21 | 2026 | 997 | 3.040 |
Why?
| | Mitochondrial Proteins | 6 | 2024 | 263 | 1.600 |
Why?
| | Neoplasm Metastasis | 7 | 2024 | 693 | 1.400 |
Why?
| | Neoplasms | 13 | 2024 | 2954 | 1.290 |
Why?
| | rho GTP-Binding Proteins | 2 | 2024 | 55 | 1.290 |
Why?
| | Mitochondrial Dynamics | 7 | 2026 | 41 | 1.230 |
Why?
| | Vesicular Transport Proteins | 3 | 2018 | 85 | 1.090 |
Why?
| | Prostatic Neoplasms | 5 | 2024 | 972 | 1.050 |
Why?
| | Nerve Tissue Proteins | 4 | 2019 | 597 | 0.980 |
Why?
| | Myosins | 2 | 2024 | 131 | 0.960 |
Why?
| | Protein Kinase C-epsilon | 5 | 2012 | 23 | 0.880 |
Why?
| | Neoplasm Invasiveness | 6 | 2024 | 504 | 0.870 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2024 | 76 | 0.840 |
Why?
| | Neoplasm Proteins | 5 | 2023 | 444 | 0.730 |
Why?
| | Cell Line, Tumor | 20 | 2025 | 3545 | 0.650 |
Why?
| | Microtubule-Associated Proteins | 2 | 2021 | 187 | 0.630 |
Why?
| | Protein Kinase C-delta | 5 | 2025 | 45 | 0.620 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 4 | 2013 | 1195 | 0.600 |
Why?
| | Cytoskeleton | 4 | 2018 | 180 | 0.590 |
Why?
| | Cell Movement | 9 | 2023 | 951 | 0.580 |
Why?
| | Signal Transduction | 13 | 2025 | 5246 | 0.570 |
Why?
| | Lung Neoplasms | 5 | 2013 | 2675 | 0.520 |
Why?
| | Membrane Proteins | 6 | 2023 | 1130 | 0.500 |
Why?
| | Cell Proliferation | 8 | 2022 | 2502 | 0.490 |
Why?
| | Enzyme Inhibitors | 3 | 2015 | 823 | 0.440 |
Why?
| | rac GTP-Binding Proteins | 2 | 2012 | 35 | 0.430 |
Why?
| | Dynamins | 3 | 2026 | 38 | 0.420 |
Why?
| | Protein Kinase C | 3 | 2013 | 250 | 0.400 |
Why?
| | Antineoplastic Agents | 5 | 2015 | 2219 | 0.390 |
Why?
| | Liver Neoplasms, Experimental | 1 | 2013 | 26 | 0.390 |
Why?
| | Animals | 21 | 2025 | 38106 | 0.360 |
Why?
| | Oxidative Phosphorylation | 3 | 2025 | 212 | 0.350 |
Why?
| | Proto-Oncogene Proteins c-akt | 5 | 2022 | 441 | 0.340 |
Why?
| | Cellular Senescence | 4 | 2020 | 225 | 0.340 |
Why?
| | Bone Neoplasms | 1 | 2013 | 272 | 0.320 |
Why?
| | Carcinoma | 1 | 2012 | 225 | 0.310 |
Why?
| | Stress, Physiological | 1 | 2013 | 450 | 0.300 |
Why?
| | NIH 3T3 Cells | 4 | 2020 | 147 | 0.290 |
Why?
| | Mice | 13 | 2024 | 18297 | 0.290 |
Why?
| | Humans | 39 | 2026 | 146342 | 0.270 |
Why?
| | Focal Adhesions | 2 | 2019 | 47 | 0.250 |
Why?
| | Dihydroxydihydrobenzopyrenes | 1 | 2006 | 1 | 0.250 |
Why?
| | MCF-7 Cells | 4 | 2025 | 133 | 0.250 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2009 | 314 | 0.250 |
Why?
| | Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2006 | 20 | 0.250 |
Why?
| | G2 Phase | 1 | 2006 | 39 | 0.250 |
Why?
| | Receptors, Androgen | 2 | 2025 | 149 | 0.240 |
Why?
| | Eukaryotic Initiation Factor-3 | 1 | 2025 | 10 | 0.230 |
Why?
| | DNA Damage | 2 | 2025 | 439 | 0.230 |
Why?
| | Palmitates | 1 | 2025 | 21 | 0.230 |
Why?
| | Guanidines | 3 | 2015 | 39 | 0.230 |
Why?
| | RNA Interference | 6 | 2016 | 472 | 0.230 |
Why?
| | Energy Metabolism | 4 | 2016 | 930 | 0.230 |
Why?
| | Sirtuins | 1 | 2025 | 50 | 0.220 |
Why?
| | Cell Division | 1 | 2006 | 736 | 0.220 |
Why?
| | A549 Cells | 3 | 2023 | 76 | 0.220 |
Why?
| | Cellular Reprogramming | 2 | 2016 | 98 | 0.220 |
Why?
| | Brain Diseases | 1 | 2026 | 159 | 0.210 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2025 | 96 | 0.210 |
Why?
| | Protein Kinases | 1 | 2006 | 311 | 0.210 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2016 | 1432 | 0.210 |
Why?
| | Small Molecule Libraries | 1 | 2025 | 113 | 0.210 |
Why?
| | Transcription, Genetic | 1 | 2011 | 1432 | 0.210 |
Why?
| | Tumor Microenvironment | 3 | 2024 | 747 | 0.200 |
Why?
| | Breast Neoplasms | 3 | 2025 | 2418 | 0.200 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2023 | 198 | 0.200 |
Why?
| | Genome-Wide Association Study | 1 | 2011 | 1537 | 0.200 |
Why?
| | Enzyme Activation | 4 | 2023 | 759 | 0.190 |
Why?
| | Apoptosis | 7 | 2025 | 2439 | 0.190 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2015 | 384 | 0.190 |
Why?
| | Receptors, Estrogen | 1 | 2025 | 406 | 0.190 |
Why?
| | Radiation Tolerance | 1 | 2023 | 101 | 0.190 |
Why?
| | HSP90 Heat-Shock Proteins | 2 | 2013 | 47 | 0.190 |
Why?
| | Protein Biosynthesis | 1 | 2025 | 449 | 0.180 |
Why?
| | Cerebral Cortex | 1 | 2026 | 485 | 0.180 |
Why?
| | Mice, Nude | 3 | 2016 | 668 | 0.180 |
Why?
| | Peptide Elongation Factors | 1 | 2022 | 15 | 0.180 |
Why?
| | Ubiquitination | 2 | 2023 | 119 | 0.180 |
Why?
| | Neoplasm Transplantation | 2 | 2013 | 238 | 0.180 |
Why?
| | Melanoma | 2 | 2020 | 765 | 0.170 |
Why?
| | Antioxidants | 1 | 2025 | 544 | 0.170 |
Why?
| | RNA, Small Interfering | 3 | 2013 | 633 | 0.170 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2599 | 0.170 |
Why?
| | Sorting Nexins | 1 | 2021 | 12 | 0.170 |
Why?
| | Transport Vesicles | 1 | 2021 | 22 | 0.170 |
Why?
| | Autophagy | 2 | 2021 | 290 | 0.160 |
Why?
| | Drug Resistance, Neoplasm | 4 | 2025 | 893 | 0.160 |
Why?
| | Coenzyme A Ligases | 1 | 2020 | 15 | 0.160 |
Why?
| | Trans-Activators | 1 | 2022 | 372 | 0.150 |
Why?
| | Myosin Type V | 1 | 2019 | 9 | 0.140 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 1 | 2019 | 54 | 0.140 |
Why?
| | Inhibitor of Apoptosis Proteins | 2 | 2016 | 45 | 0.140 |
Why?
| | Androgens | 1 | 2019 | 179 | 0.140 |
Why?
| | Phosphorylation | 5 | 2015 | 1724 | 0.140 |
Why?
| | Neurons | 2 | 2026 | 1668 | 0.130 |
Why?
| | Aging | 1 | 2009 | 1996 | 0.130 |
Why?
| | RNA-Binding Proteins | 1 | 2022 | 465 | 0.130 |
Why?
| | Myosin Heavy Chains | 1 | 2019 | 177 | 0.130 |
Why?
| | Drug Evaluation, Preclinical | 2 | 2015 | 195 | 0.130 |
Why?
| | Glucuronidase | 1 | 2017 | 27 | 0.130 |
Why?
| | Wnt-5a Protein | 1 | 2017 | 25 | 0.120 |
Why?
| | Gene Knockdown Techniques | 2 | 2019 | 335 | 0.120 |
Why?
| | Cell Line | 4 | 2023 | 2814 | 0.120 |
Why?
| | Microtubules | 1 | 2019 | 226 | 0.120 |
Why?
| | Cell Survival | 4 | 2015 | 1105 | 0.120 |
Why?
| | Molecular Targeted Therapy | 2 | 2020 | 447 | 0.120 |
Why?
| | Endopeptidase Clp | 1 | 2016 | 4 | 0.120 |
Why?
| | Mice, SCID | 2 | 2016 | 360 | 0.120 |
Why?
| | Adenosine Triphosphate | 1 | 2019 | 494 | 0.120 |
Why?
| | Lactams, Macrocyclic | 2 | 2013 | 51 | 0.120 |
Why?
| | Thiazolidinediones | 1 | 2017 | 142 | 0.120 |
Why?
| | Disease Progression | 2 | 2015 | 2867 | 0.120 |
Why?
| | Isoenzymes | 3 | 2013 | 294 | 0.120 |
Why?
| | Metabolic Networks and Pathways | 1 | 2016 | 175 | 0.110 |
Why?
| | Adaptation, Biological | 1 | 2015 | 48 | 0.110 |
Why?
| | Elafin | 1 | 2015 | 1 | 0.110 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2017 | 231 | 0.110 |
Why?
| | Fibroblasts | 1 | 2020 | 1034 | 0.100 |
Why?
| | Down-Regulation | 1 | 2016 | 614 | 0.100 |
Why?
| | Phorbol Esters | 2 | 2011 | 13 | 0.100 |
Why?
| | Tetradecanoylphorbol Acetate | 3 | 2010 | 128 | 0.100 |
Why?
| | Male | 11 | 2024 | 73396 | 0.100 |
Why?
| | Biological Transport | 1 | 2015 | 424 | 0.100 |
Why?
| | Cell Adhesion | 1 | 2015 | 447 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-rel | 1 | 2013 | 7 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 3 | 2020 | 983 | 0.100 |
Why?
| | Autophagy-Related Protein-1 Homolog | 1 | 2013 | 6 | 0.100 |
Why?
| | Regulatory Elements, Transcriptional | 1 | 2013 | 18 | 0.100 |
Why?
| | Hexokinase | 1 | 2013 | 18 | 0.100 |
Why?
| | Adenylate Kinase | 1 | 2013 | 26 | 0.100 |
Why?
| | Mitochondrial Membranes | 1 | 2013 | 40 | 0.100 |
Why?
| | Skin Neoplasms | 1 | 2020 | 806 | 0.090 |
Why?
| | Carcinogens | 2 | 2011 | 112 | 0.090 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 1998 | 0.090 |
Why?
| | Unfolded Protein Response | 1 | 2012 | 58 | 0.090 |
Why?
| | Oxygen Consumption | 1 | 2015 | 721 | 0.090 |
Why?
| | Cell Death | 2 | 2025 | 379 | 0.090 |
Why?
| | Guanosine Triphosphate | 1 | 2012 | 88 | 0.090 |
Why?
| | Genes, bcl-2 | 1 | 2011 | 21 | 0.090 |
Why?
| | Glioblastoma | 1 | 2015 | 350 | 0.080 |
Why?
| | Up-Regulation | 3 | 2023 | 841 | 0.080 |
Why?
| | Rift Valley fever virus | 1 | 2010 | 3 | 0.080 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2011 | 162 | 0.080 |
Why?
| | Protein Kinase C-alpha | 2 | 2008 | 37 | 0.080 |
Why?
| | Cell Hypoxia | 2 | 2025 | 249 | 0.080 |
Why?
| | Reactive Oxygen Species | 2 | 2025 | 610 | 0.080 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 319 | 0.080 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 970 | 0.080 |
Why?
| | Etoposide | 1 | 2011 | 169 | 0.080 |
Why?
| | Clinical Trials as Topic | 1 | 2015 | 1064 | 0.080 |
Why?
| | Insecta | 1 | 2010 | 73 | 0.080 |
Why?
| | Protein Processing, Post-Translational | 1 | 2013 | 487 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2013 | 457 | 0.080 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2010 | 153 | 0.080 |
Why?
| | Mutation | 4 | 2026 | 4093 | 0.080 |
Why?
| | Diglycerides | 1 | 2010 | 66 | 0.080 |
Why?
| | GTPase-Activating Proteins | 1 | 2010 | 81 | 0.080 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2011 | 178 | 0.070 |
Why?
| | Female | 7 | 2025 | 79499 | 0.070 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 752 | 0.070 |
Why?
| | Promoter Regions, Genetic | 1 | 2013 | 1242 | 0.070 |
Why?
| | S Phase | 1 | 2007 | 77 | 0.070 |
Why?
| | Peptide Fragments | 1 | 2011 | 693 | 0.060 |
Why?
| | Extracellular Matrix | 1 | 2012 | 565 | 0.060 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 104 | 0.060 |
Why?
| | Checkpoint Kinase 1 | 1 | 2006 | 27 | 0.060 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2006 | 163 | 0.060 |
Why?
| | Phenylthiohydantoin | 1 | 2025 | 44 | 0.060 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2025 | 49 | 0.060 |
Why?
| | Brain Neoplasms | 1 | 2015 | 1325 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2010 | 1224 | 0.060 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2025 | 120 | 0.050 |
Why?
| | Benzamides | 1 | 2025 | 226 | 0.050 |
Why?
| | Mice, Inbred NOD | 2 | 2016 | 598 | 0.050 |
Why?
| | Nitriles | 1 | 2025 | 212 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1792 | 0.050 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2025 | 299 | 0.050 |
Why?
| | Pentose Phosphate Pathway | 1 | 2023 | 55 | 0.050 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2026 | 269 | 0.050 |
Why?
| | Glutamine | 1 | 2023 | 110 | 0.050 |
Why?
| | Nucleotides | 1 | 2023 | 128 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2017 | 930 | 0.050 |
Why?
| | Neoplastic Processes | 1 | 2022 | 5 | 0.040 |
Why?
| | Protein Folding | 2 | 2015 | 281 | 0.040 |
Why?
| | Autophagy-Related Protein 7 | 1 | 2021 | 13 | 0.040 |
Why?
| | Models, Biological | 1 | 2009 | 1761 | 0.040 |
Why?
| | Glycolysis | 1 | 2023 | 342 | 0.040 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 46 | 0.040 |
Why?
| | Lysosomes | 1 | 2021 | 134 | 0.040 |
Why?
| | Cytosol | 2 | 2012 | 215 | 0.040 |
Why?
| | Dermis | 1 | 2020 | 31 | 0.040 |
Why?
| | Muscle Proteins | 1 | 2022 | 242 | 0.040 |
Why?
| | Voltage-Dependent Anion Channels | 1 | 2019 | 1 | 0.040 |
Why?
| | Endosomes | 1 | 2021 | 139 | 0.040 |
Why?
| | Pyruvates | 1 | 2019 | 23 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2022 | 219 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2019 | 58 | 0.040 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2019 | 46 | 0.040 |
Why?
| | Dihydrotestosterone | 1 | 2019 | 40 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2020 | 245 | 0.040 |
Why?
| | Keratinocytes | 1 | 2020 | 190 | 0.040 |
Why?
| | Cells, Cultured | 1 | 2026 | 4118 | 0.030 |
Why?
| | Glucose | 1 | 2023 | 1053 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2020 | 533 | 0.030 |
Why?
| | Succinate Dehydrogenase | 1 | 2016 | 65 | 0.030 |
Why?
| | Transplantation, Heterologous | 1 | 2016 | 165 | 0.030 |
Why?
| | PPAR gamma | 1 | 2017 | 182 | 0.030 |
Why?
| | Protein Subunits | 1 | 2016 | 225 | 0.030 |
Why?
| | Cyclophilins | 1 | 2015 | 40 | 0.030 |
Why?
| | Rats | 1 | 2023 | 5586 | 0.030 |
Why?
| | Cell Cycle | 2 | 2008 | 595 | 0.030 |
Why?
| | Drug Synergism | 1 | 2015 | 354 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2015 | 201 | 0.020 |
Why?
| | Indoles | 1 | 2017 | 511 | 0.020 |
Why?
| | Sulfonamides | 1 | 2017 | 594 | 0.020 |
Why?
| | Heat-Shock Proteins | 1 | 2012 | 140 | 0.020 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2012 | 141 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2013 | 882 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2013 | 369 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2012 | 168 | 0.020 |
Why?
| | Benzophenanthridines | 1 | 2010 | 10 | 0.020 |
Why?
| | Acetophenones | 1 | 2010 | 13 | 0.020 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2012 | 193 | 0.020 |
Why?
| | Vero Cells | 1 | 2010 | 84 | 0.020 |
Why?
| | Benzopyrans | 1 | 2010 | 31 | 0.020 |
Why?
| | bcl-Associated Death Protein | 1 | 2010 | 10 | 0.020 |
Why?
| | Diptera | 1 | 2010 | 31 | 0.020 |
Why?
| | Immunoblotting | 1 | 2010 | 294 | 0.020 |
Why?
| | Endoplasmic Reticulum | 1 | 2012 | 268 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2010 | 345 | 0.020 |
Why?
| | COS Cells | 1 | 2010 | 173 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 3347 | 0.020 |
Why?
| | Proteomics | 1 | 2016 | 1203 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2012 | 455 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2016 | 3125 | 0.020 |
Why?
| | HeLa Cells | 1 | 2010 | 636 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2010 | 750 | 0.020 |
Why?
| | beta-Galactosidase | 1 | 2007 | 73 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 6034 | 0.020 |
Why?
| | Adenoviridae | 1 | 2008 | 197 | 0.020 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2010 | 429 | 0.020 |
Why?
| | Proteins | 1 | 2012 | 1022 | 0.010 |
Why?
| | Telomerase | 1 | 2007 | 252 | 0.010 |
Why?
| | Middle Aged | 2 | 2017 | 36619 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2016 | 8391 | 0.010 |
Why?
| | Adult | 2 | 2017 | 41087 | 0.010 |
Why?
| | Aged | 1 | 2016 | 26432 | 0.010 |
Why?
|
|
Caino's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|